Carlyle Investment Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Carlyle Investment Management LLC
CRD #111128
SEC #801-52462
CIK #0001354120, 0001527166
AUM 283.81 B (2026-03-31)
Employees 1,040 (30% Investors, 0% Brokers)
Fees
Minimum
Phone202-729-5626
Address1001 Pennsylvania Avenue, NW
Washington, DC 20004-2505
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram]
Total AUM ($B)
3002401801206001999200820172027
Fees and Compensation — Form ADV Part 2A (7/7/2026) [Brochure]
Item 5. Fees and Compensation

CIM or its affiliates 4 generally receive management fees, incentive fees, carried interest or similar
profit allocations from Advisory Clients. Advisory Clients frequently also indirectly incur or
generate other fees payable to CIM or its affiliates, depending on the nature of their portfolio
activities. CIM or its affiliates, for example, earn fees and other compensation from prospective
and actual portfolio companies, purchasers, sellers and other parties as compensation for services
(collectively, “Service Fees”). These Service Fees can include project, structuring, topping,
termination, break-up, directors’, organizational, set-up, investment banking, underwriting,
syndication, closing, commitment, advisory, consulting, amendment, servicing, and other similar
fees in connection with the purchase, monitoring, or disposition of underlying investments
(including warrants, options, derivatives and other rights in respect of securities) or from
unconsummated transactions. In general, the specific legal and/or organizational documents of the
relevant Advisory Client, the investment management agreement between CIM (or an affiliate)
and such Advisory Client or the agreements in respect of the portfolio investments describe the
basic fee structure relevant to the investors in such Advisory Client. To the extent provided in such
organizational documents or investment management agreement, CIM’s management fees from
Advisory Clients generally are reduced (offset) by a specified portion of the Service Fees that arise
out of such Advisory Client’s investment activities. The Service Fees can be and often are
substantial, and if not fully offset pursuant to organizational documents will be indirectly borne by
investors.

Certain fees are excluded from the definition of “Service Fees” and not subject to a management
fee offset. For certain Advisory Clients, capital markets fees earned by GCM (which includes a
broker-dealer affiliate of CIM that is a U.S.-registered broker-dealer and other affiliates providing
similar services with respect to loans) for conducting a financial services, loan origination,
structuring, placement or other similar business, including, for example, as a broker, dealer,
distributor, syndicator, arranger, servicer or originator of securities or loans, are not considered
“Service Fees” subject to any management fee offset. As described in more detail below, these
capital markets fees include offering, placement, financing, syndication, capital structure advisory,
turnaround, workout, underwriting, solicitation, investment banking, currency, hedging,
structuring, loan agent, loan servicing, rating advisory or similar fees in connection with the
activities of an Advisory Client and its portfolio companies, including with respect to an initial
public offering or private placement, the arranging or provision of credit facilities (including any
related extensions or refinancing) for an Advisory Client or one of its portfolio companies and
other vehicles managed or controlled by Carlyle, the placing of co-investment, the distribution or

  For the purposes of this Brochure, references to “CIM or its affiliates” or “CIM and its affiliates” do not include
references to Carlyle-affiliated advisers, such as CGCIM, AlpInvest, CASP and CAPDP, unaffiliated advisers, such
as Atlas NV, NGP and Riverstone, or any Carlyle portfolio companies, including portfolio companies that are
investment advisers registered with the SEC (e.g., Content Partners LLC, or the separately registered investment
advisers affiliated with TCW Group, Inc.).

placement of loans or equity securities of an Advisory Client portfolio company or otherwise
arranging or providing financing for such portfolio company alone or with other lenders, which
could include other vehicles managed or controlled by Carlyle (any such fees, “GCM Fees”). GCM
may manage or otherwise participate in underwriting syndicates and/or selling groups with respect
to the securities and/or loans and debt instruments of portfolio companies and other non-controlled
entities in or through which certain Advisory Clients invest, including in respect of securities or
other instruments of such portfolio companies in which Advisory Clients have not invested. GCM
also manages or otherwise participates in underwriting syndicates and/or selling groups with
respect to securities and/or loans and other instruments held directly or indirectly by certain co-
investment vehicles. Further, GCM will be involved in the public offering or private placement of
such securities and/or loans and other instruments, and/or sometimes provide capital markets
advisory services to portfolio companies and other non-controlled entities in or through which
Advisory Clients invest, including in connection with mergers, acquisitions, and restructurings;
and will alone, or with other counterparties, provide acquisition financing, lines of credit and other
corporate lending or financing products and services to such entities in addition to financing
provided through an Advisory Client’s investment. In addition, certain of Carlyle’s investment
advisory professionals will be involved in such activities of GCM, and their activities are expected
to give rise to GCM Fees that are not subject to any management fee offset, even though such
persons are involved in investment-related activities on behalf of one or more Advisory Clients.
In addition, fees attributable to co-investors or internal or external co-investment vehicles and fees
eligible to be treated as expenses of an Advisory Client are expected to also be retained by Carlyle
and its affiliates, including GCM, and excluded from “Service Fees” and not subject to a
management fee offset.

Other than transactions expressly permitted by the governing agreements of the relevant Advisory
Client, any fees paid to CIM or its affiliates by a portfolio company or an Advisory Client are
...
Account Minimums and Types of Clients — Form ADV Part 2A (7/7/2026) [Brochure]
Item 7. Types of Clients

The vast majority of CIM’s Advisory Clients are pooled investment vehicles. CIM also provides
advisory services on a separately managed account basis to, among others, entities associated with
non-U.S. and U.S. state and local governments and their instrumentalities. CIM also provides other
advisory, sub-advisory and co-advisory services as described above.

CIM and its affiliates typically require that each third-party investor in an Advisory Client be an
“accredited investor” as defined in Regulation D under the Securities Act and a “qualified
purchaser” as defined in the 1940 Act. Typically, a minimum investment amount is imposed on
third parties investing in the investment vehicles for which CIM acts as investment adviser or
collateral manager (through its relying advisers, including ALLP, Carlyle CLO, CBAM CLO and
Carlyle CLO Europe). This minimum often is set at $5-10 million, but can be subject to a reduction
upon prior agreement by CIM or an affiliate (subject to applicable legal requirements) and is often
much lower for investment vehicles targeted at high-net worth individuals. A minimum investment
amount can also be established pursuant to the laws of the jurisdiction in which the investment
vehicle was established.
Sector Form 13F Holdings Value ($B)
Medline Inc 8.3
Standardaero Inc 2.2
Phathom Pharmaceuticals Inc 0.0
PONY AI Inc 0.0
Invitation Homes Inc 0.0
U-Store-It Trust 0.0
Homology Medicines Inc 0.0
Getty Images Holdings Inc 0.0
Spruce Biosciences Inc 0.0
Forward Air Corp 0.0
View All
Holdings by Sector ($B)
2016128402011201620212027
Type Form D Funds Date Sold AUM
PE Abingworth Clinical Co-Development Fund 3 [2026-03-31] 65.9 M
Filed 2025-06-25 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $6,000,000 · Revenue Decline to Disclose
PE ACCD 3 SMRS Co-Invest LP 2026-03-31
PE Carlyle Bluebird SMA LP 2026-03-31
SA Carlyle Euro CLO 2013-1 DAC 2026-03-31 540.9 M
SA Carlyle Euro CLO 2025-1 DAC 2026-03-31 744.7 M
SA Carlyle Euro CLO 2025-2 DAC 2026-03-31 596.1 M
SA Carlyle Euro CLO 2025-CE DAC 2026-03-31 263.7 M
SA Carlyle Euro CLO 2025-DE DAC 2026-03-31 100.8 M
RE Carlyle Europe Realty Fund III 2026-03-31
PE Carlyle Global Infrastructure Opportunity Fund II 2026-03-31
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 595 203.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 1 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 15 80.4
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 1 0.0
Total 612 283.8
By Discretionary
Discretionary 602 200.8
Non-Discretionary 10 83.1
Total 612 283.8
By Non-United States Persons
Non-United States Persons 122.6
United States Persons 161.2
Total 612 283.8
Limited Partners2011 - 2026
Alaska Permanent Fund Corporation
Baltimore County Fire and Police Employees' Retirement System
California Public Employees' Retirement System
California State Teachers' Retirement System
Houston Police Officers' Pension System
Los Angeles County Employees Retirement Association
Maine Public Employees Retirement System
Maryland State Retirement and Pension System
Massachusetts Pension Reserves Investment Management
Minnesota State Board of Investment
Missouri Public School Retirement System
New Hampshire Retirement System
New Jersey Division of Investment
New York City Board of Education Retirement System
New York City Employees' Retirement System
New York State and Local Retirement System
New York State Common Retirement Fund
Oregon Public Employees Retirement Fund
Pennsylvania Public School Employees' Retirement System
Pennsylvania State Employees' Retirement System
Sixth Swedish National Pension Fund
South Carolina Public Employees Benefit Authority
South Dakota Investment Council
State Board of Administration of Florida
State of Michigan Retirement System
State Teachers Retirement System of Ohio
Teachers' Retirement Security for Illinois Educators
Teachers' Retirement System of the City of New York
Virginia Retirement System
Washington State Investment Board
Form D Directors Role # Filings # Firms 2011 - 2026
Sean Flynn Director 165 41
Patrick Harrigan Director 135 40
Tej Gujadhur Director 51 16
Laurence Tosi Executive Officer 167 14
Santosh Gujadhur Director 29 10
Jonathan Gray Executive Officer 94 9
Anthony Beovich Executive Officer 172 8
Dennis McDonagh Executive Officer 40 7
Michael Nash Executive Officer 53 6
Judy Turchin Executive Officer 42 6
View All
EDGAR Form CIK 2011 - 2026
13F-NT [0001354120]
3 [0001354120]
4 [0001354120]
SC 13D [0001354120]
SC 13G [0001354120]
10-K [0001527166]
10-Q [0001527166]
13F-HR [0001527166]
3 [0001527166]
4 [0001527166]
8-K [0001527166]
SC 13D [0001527166]
SC 13G [0001527166]
Form 13D/13G Filer Form 13D/13G Subject Filed
Carlyle Group Inc Medline Inc [2026-02-13]
Capital World Investors Carlyle Group Inc [2025-08-13]
Carlyle Group Inc Standardaero Inc [2025-02-12]
Carlyle Group Inc CANO Health Inc [2024-07-08]
Carlyle Group Inc Q32 Bio Inc [2024-03-29]
Capital World Investors Carlyle Group Inc [2024-02-09]
BlackRock Inc Carlyle Group Inc [2024-01-25]
Carlyle Group Inc Complete Solaria Inc [2023-09-22]
Carlyle Group Inc Phathom Pharmaceuticals Inc [2023-03-09]
Carlyle Group Inc Vertical Capital Income Fund [2023-01-23]
View All
Firm Profile (Form ADV)
Discretionary AUM$107.7B
Clients16 (67 non-US)
ServesInstitutional
Fund TypesHedge Fund, Private Equity, Real Estate
LEI549300MVJ5FAYQX68835
Related People Network
132 people file Form D offerings alongside this firm's people, tied to 28 other firms through shared filers.
Form 3/4/5 Subject 2011 - 2026
Carlyle Group Inc
Heinzelman Kate Elizabeth
Ferguson Jeffrey W
Nedelman Jeffrey
Andrews Charles Elliott Jr
Redett John C
LoBue Lindsay
Plouffe Justin
Jenkins Mark David
Schwartz Harvey M
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Carlyle Group Inc CG
Common Stock
2026-03-19 Sell 500,000 $46.68 23,340,000
Carlyle Group Inc CG
Common Stock
2026-03-19 Gift 100,000 $0.00
Medline Inc MDLN
Class A Common Stock
2026-03-10 Other 2,113,483
Medline Inc MDLN
Class A Common Stock
2026-03-10 Sell 26,105,840 $41.00 1,070,339,440
Medline Inc MDLN
Class B Common Stock
2026-03-05 Other 1,212,767
Medline Inc MDLN
Class A Common Stock
2026-03-05 Conversion 1,212,767
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
2026-03-05 Conversion 1,212,767 $0.00
Medline Inc MDLN
Class B Common Stock
2026-03-04 Other 8,085,116
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
2026-03-04 Conversion 8,085,116 $0.00
Medline Inc MDLN
Class A Common Stock
2026-03-04 Conversion 8,085,116
StandardAero Inc SARO
Common Stock
2026-02-26 Sell 19,840,268 $31.46 624,174,831
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 3,431 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 6,424 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 343 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 9,114 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 17,457 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 1,070 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 2,625 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-20 Grant 6,507 $0.00
Carlyle Group Inc CG
Common Stock
2026-02-14 Tax withheld 134,812 $54.49 7,345,906
showing 20 of 200 most recent transactions
Related Firms State AUM
Carlyle Investment Management LLC
DC 283.81 B
Carlyle Global Credit Investment Management LLC
NY 68.38 B
AlpInvest Partners BV
39.88 B
Carlyle Aviation Securities Partners LLC
FL 1,136.0 M
Comparable Firms State AUM
Ares Management LLC
CA 458.82 B
Point72 Asset Management LP
CT 274.10 B
HPS Investment Partners LLC
NY 175.72 B
Nuveen Alternatives Advisors LLC
NY 142.02 B
APG Asset Management US Inc
NY 141.33 B
Corebridge Institutional Investments US LLC
NJ 121.05 B
Angelo Gordon & Co LP
NY 115.94 B
StepStone Group LP
CA 107.82 B
Brookfield Asset Management PIC US LLC
NY 105.30 B
Oak Hill Advisors LP
NY 100.72 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com